<!DOCTYPE html lang="EN">
<html>
<head>
	
	<meta content="text/html; charset=UTF-8" http-equiv="Content-Type" />
	<title>Hormonal Replacement in Hypopituitarism in Adults_2017</title>
	<meta content="width=device-width; initial-scale=1.0; maximum-scale=1.5; user-scalable=1;" name="viewport" />
	<link charset="UTF-8" href="ENAS5297.css" rel="STYLESHEET" type="text/css" />
	<link charset="UTF-8" href="HighLight.css" rel="STYLESHEET" type="text/css" /><script src="jquery-2.0.31.min.js"></script><script type = "text/javascript" src = "HighlightSearch.js"></script>
	 <link rel="stylesheet" type="text/css" href="calci_std.css">
	 <link rel="stylesheet" type="text/css" href="ENAS5329.css">
</head>
<body onload="_geturl1();">

<table class="table">
	<colgroup>
		<col width="25%" />
		<col width="50%" />
		<col width="25%" />
	</colgroup>
	<tbody>
		<tr>
			<th class="table-header1" colspan="3">
			<p class="table-title1">Table 7 Doses of fib&shy;ri&shy;nolyt&shy;ic agents and an&shy;tithrom&shy;bot&shy;ic co-&zwj;ther&shy;a&shy;pies</p>
			</th>
		</tr>
		<tr>
			<th class="table-header2">
			<p class="table-title2">Drug</p>
			</th>
			<th class="table-header2">
			<p class="table-title2">Ini&shy;tial treat&shy;ment</p>
			</th>
			<th class="table-header2">
			<p class="table-title2">Spe&shy;cif&shy;ic con&shy;tra-&zwj;in&shy;di&shy;ca&shy;tions</p>
			</th>
		</tr>
		<tr>
			<th class="table-header3" colspan="3">
			<p class="table-title3">Doses of fib&shy;ri&shy;nolyt&shy;ic ther&shy;a&shy;py</p>
			</th>
		</tr>
		<tr>
			<td class="col-purple">
			<p class="table-text">Strep&shy;tok&shy;i&shy;nase</p>
			</td>
			<td class="col-purple">
			<p class="table-text">1.5 mil&shy;lion units over 30&ndash;60 min <span class="italic">i.v.</span></p>
			</td>
			<td class="col-purple">
			<p class="table-text">Pre&shy;vi&shy;ous treat&shy;ment with strep&shy;tok&shy;i&shy;nase or anistre&shy;plase</p>
			</td>
		</tr>
		<tr>
			<td>
			<p class="table-text">Al&shy;teplase (tPA)</p>
			</td>
			<td>
			<p class="table-text">15 mg <span class="italic">i.v.</span> bolus</p>

			<p class="table-text">0.75 mg/kg <span class="italic">i.v.</span> over 30 min (up to 50 mg) then 0.5 mg/kg <span class="italic">i.v.</span> over 60 min (up to 35 mg)</p>
			</td>
			<td>&nbsp;</td>
		</tr>
		<tr>
			<td class="col-purple">
			<p class="table-text">Rete&shy;plase (rPA)</p>
			</td>
			<td class="col-purple">
			<p class="table-text">10 units + 10 units <span class="italic">i.v.</span> bolus given 30 min apart</p>
			</td>
			<td class="col-purple">&nbsp;</td>
		</tr>
		<tr>
			<td>
			<p class="table-text">Te&shy;nec&shy;te&shy;pla&shy;se (TNK-&zwj;&shy;tPA)</p>
			</td>
			<td>
			<p class="table-text">Sin&shy;gle <span class="italic">i.v.</span> bolus:</p>

			<p class="indent">30 mg (6000 IU) if &lt;60 kg</p>

			<p class="indent">35 mg (7000 IU) if 60 to &lt;70 kg</p>

			<p class="indent">40 mg (8000 IU) if 70 to &lt;80 kg</p>

			<p class="indent">45 mg (9000 IU) if 80 to &lt;90 kg</p>

			<p class="indent">50 mg (10000 IU) if &ge; 90 kg</p>

			<p class="indent">It is rec&shy;om&shy;mend&shy;ed to re&shy;duce to half-&zwj;dose in pa&shy;tients &ge;75 years of age.</p>
			</td>
			<td>&nbsp;</td>
		</tr>
		<tr>
			<th class="table-header3" colspan="3">
			<p class="table-title3">Doses of an&shy;tiplatelet co-&zwj;ther&shy;a&shy;pies</p>
			</th>
		</tr>
		<tr>
			<td class="col-purple">
			<p class="table-text">As&shy;pirin</p>
			</td>
			<td class="col-purple">
			<p class="table-text">Start&shy;ing dose of 150&ndash;300 mg oral&shy;ly (or 75&ndash;250 mg in&shy;tra&shy;venously if oral in&shy;ges&shy;tion is not pos&shy;si&shy;ble), fol&shy;lowed by a main&shy;te&shy;nance dose of 75&ndash;100 mg/&zwj;day.</p>
			</td>
			<td class="col-purple">&nbsp;</td>
		</tr>
		<tr>
			<td>
			<p class="table-text">Clopi&shy;do&shy;grel</p>
			</td>
			<td>
			<p class="table-text">Load&shy;ing dose of 300 mg oral&shy;ly, fol&shy;lowed by a main&shy;te&shy;nance dose of 75 mg/&zwj;day.</p>

			<p class="table-text">In pa&shy;tients &ge;75 years of age: load&shy;ing dose of 75 mg, fol&shy;lowed by a main&shy;te&shy;nance dose of 75 mg/&zwj;day.</p>
			</td>
			<td>&nbsp;</td>
		</tr>
		<tr>
			<th class="table-header3" colspan="3">
			<p class="table-title3">Doses of an&shy;ti&shy;co&shy;ag&shy;u&shy;lant co-&zwj;ther&shy;a&shy;pies</p>
			</th>
		</tr>
		<tr>
			<td rowspan="2">
			<p class="table-text">Enoxa&shy;parin</p>
			</td>
			<td>
			<p class="table-text">In pa&shy;tients &lt;75 years of age:</p>

			<p class="indent">30 mg <span class="italic">i.v.</span> bolus fol&shy;lowed 15 min later by 1 mg/kg <span class="italic">s.c.</span> every 12 hours until revas&shy;cu&shy;lar&shy;iza&shy;tion or hos&shy;pi&shy;tal dis&shy;charge for a max&shy;i&shy;mum of 8 days.The first two <span class="italic">s.c.</span> doses should not ex&shy;ceed 100 mg per in&shy;jection.</p>
			</td>
			<td>&nbsp;</td>
		</tr>
		<tr>
			<td>
			<p class="table-text">In pa&shy;tients &ge; 75 years of age:</p>

			<p class="indent">no <span class="italic">i.v.</span> bolus; start with first <span class="italic">s.c.</span> dose of 0.75 mg/kg with a max&shy;i&shy;mum of 75 mg per in&shy;jection for the first two <span class="italic">s.c.</span> doses.</p>

			<p class="table-text">In pa&shy;tients with eGFR &lt;30 mL/&zwj;min/&zwj;1.73 m<span class="text-sup">2</span>, re&shy;gard&shy;less of age, the <span class="italic">s.c.</span> doses are given once every 24 hours.</p>
			</td>
			<td>&nbsp;</td>
		</tr>
		<tr>
			<td class="col-purple">
			<p class="table-text">UFH</p>
			</td>
			<td class="col-purple">
			<p class="table-text">60 IU/kg <span class="italic">i.v.</span> bolus with a max&shy;i&shy;mum of 4000 IU fol&shy;lowed by an <span class="italic">i.v.</span> in&shy;fu&shy;sion of 12 IU/kg with a max&shy;i&shy;mum of 1000 IU/&zwj;hour for 24&ndash;48 hours. Tar&shy;get aPTT: 50&ndash;70 s or 1.5 to 2.0 times that of con&shy;trol to be mon&shy;i&shy;tored at 3, 6, 12 and 24 hours.</p>
			</td>
			<td class="col-purple">&nbsp;</td>
		</tr>
		<tr>
			<td>
			<p class="table-text">Fon&shy;da&shy;parin&shy;ux (only with strep&shy;tok&shy;i&shy;nase)</p>
			</td>
			<td>
			<p class="table-text">2.5 mg <span class="italic">i.v.</span> bolus fol&shy;lowed by a <span class="italic">s.c.</span> dose of 2.5 mg once daily up to 8 days or hos&shy;pi&shy;tal dis&shy;charge.</p>
			</td>
			<td>&nbsp;</td>
		</tr>
	</tbody>
</table>

<br>

        <div style="float:right; width:70px; paddin:0px 0px 3px 0px;   ">
                <button id="pdf_button"  class="flip-pdf-button"  >
                    <a href="flipView"> <img src="algo.png" class="pdf-image "></img></a>
                </button>
        </div>
		<br/>
		<br/>
		 <div class="static-reference-box">
  <p class="text_left">aPTT = activated partial thromboplastin time; eGFR = estimated glomerular filtration rate; <i>i.v.</i> = intravenous; IU = international units; rPA = recombinant plasminogen activator; <i>s.c.</i> = subcutaneous; tPA = tissue plasminogen activator; UFH = unfractionated heparin.
                       </p>
                        </div>
						<div class="static-reference-box">
  <p class="text_left">*Doses of fibrinolytic therapy<br/>**Doses of antiplatelet co-therapies<br/>***Doses of anticoagulant co-therapies
                       </p>
                        </div>
     
</body>
</html>
